Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Butyrate triglyceride is increasingly studied for its potential role in metabolic syndrome, a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. The scientific rationale for its use stems from the known benefits of butyrate, a short-chain fatty acid produced by gut microbiota during the fermentation of dietary fiber. Butyrate has demonstrated several metabolic benefits in preclinical models, including improved insulin sensitivity, reduced inflammation, and modulation of energy expenditure. Triglyceride esters of butyrate are used as a delivery form to enhance its absorption and targeted release in the intestine. Several animal studies have shown that butyrate supplementation can improve glucose metabolism, decrease hepatic fat accumulation, and reduce body weight gain in models of diet-induced obesity and metabolic syndrome. For example, mice given butyrate or butyrate-containing triglycerides exhibit improved insulin sensitivity and reduced adiposity. Some early human studies also suggest that butyrate may improve metabolic markers, though these are limited and often use sodium butyrate or dietary fiber rather than the triglyceride form. While the evidence is promising, most of the supportive data comes from animal studies or small-scale human interventions. Large, well-controlled clinical trials in humans using butyrate triglyceride specifically are still lacking. Thus, the current scientific evidence supports a potential benefit but is not yet robust enough for unequivocal clinical endorsement.

More about butyrate triglyceride
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by butyrate triglyceride

Products containing butyrate triglyceride